BTDG Archives - Blue Horseshoe Stocks

GS, PEP Options Review, Fresh Ideas & More

GS, PEP Options Breakout:

With the earnings drought just days away from finally ending, we still have been managing to seek out winning plays. As we’ve said, next week begins a torrential outpouring of quarterly reporters on the order of dozens, if not hundreds per day!

We got back on the track of options perfection yesterday, with both of our fresh ideas in our premarket report yielding stellar intraday chances to profit. We had selected the GS Weekly $380-385 Calls and the PEP Weekly $149-152.50 Calls following Goldman Sachs and Pepsi’s earnings releases.

Despite an up-and-down sort of a session for the markets at large, we witnessed some serious multibag moves from every single contract we slated for observation. Here are the total possible gains that traders could have logged on the strength of those ideas:

GS Weekly $380-385 Calls
$380: 1.64-4.69 (+186%)
$382.50: 1.19-3.68 (+209%)
$385: .85-2.89 (+240%)
_____

PEP Weekly $149-152.50 Calls
$149: 2.20-4.95 (+125%)
$150: 1.50-4.00 (+167%)
$152.50: .43-1.73 (+302%)

Fresh Options Ideas:
SPY 07/14 $436-437 Calls*
C Weekly $69-70 Calls

*Please be aware that these SPY Calls will expire at the end of the trading day. Trading options on the day of their expiration is a high-risk/high-reward proposition that should only be undertaken by experienced traders!

Extended Watchlist:
OXBR, XELA, JZXN, MINM, CTIB, DTSS, RMRK, CYBL, BLEG, MSAV, BTDG, CRSM

Tons of Options Plays

BioNTech (SE) BNTX – Options Recap:

Yesterday morning, our premarket report featured a couple of options ideas, one of which was in BNTX. This came right on the heels of the company’s revelation that its COVID-19 vaccine developed in partnership with Pfizer has demonstrated a 100% efficacy rate in adolescent recipients.

That news provided at least some of the impetus for for our targets, the BNTX Weekly $99-101 Calls, to produce the following multibag intraday gain opportunities for anyone who caught our alert:

BNTX Weekly $99-101 Calls
$99: 2.90-7.00 (+141%)
$100: 2.15-6.80 (+216%)
$101: 2.30-5.30 (+130%)

We’ll be looking to extend these gains once again today, and will roll up to include the BNTX Weekly $105-107 Calls in our watchlist for the remainder of this short week.
____

AbCellera Biologics, Inc. ABCL – Our other fresh options idea from yesterday was a longer-term target with a couple weeks still remaining until expiration, but we saw instant results after calling the timing of the reversal perfectly:

ABCL 04/16 $25 Calls
$25: 1.75-3.00 (+71%)

Fresh Options Ideas:
CHWY Weekly $90-93 Calls
LULU Weekly $315-310 Puts
WBA Weekly $53-54 Calls

Extended Watchlist:
RSCF, INND, KYNC, TMGI, INKW, FTXP, BTDG

Blue Horseshoe Stocks: Monday’s Movers, Bottom-Play & More

Yesterday’s Movers

B2Digital, Inc. BTDG – One of the stocks that we were looking at from yesterday morning‘s extended watchlist was BTDG. This super-subpenny play made its move right from the opening bell, and by the time the first hour of trading had elapsed, the stock had recorded a double-bag move to the upside.

BTDG traded in a range from its low of .0004, and hit .0008- a perfectly symmetrical 100% rip. The stock closed at its dily mid-point of .0006, and with the kind of volatile price action we’ve observed, we’ll be certain to keep an eye peeled in sessions to come.

______

Novus Acquisition & Development Corp. NDEV – The other notable mention from yesterday’s report was NDEV. We noticed this one had just perked up after a sustained period of lethargic trading the day prior, and the trend continued.

The stock traded in a solid range from .30-.442, an intraday push of 47%, and perhaps most notably, closed with strength at .43 after having traded roughly two-and-a-half times its 30-day average volume. That’s sufficient to warrant further observation, thus NDEV will remain an item of interest for us.

DAVIDs TEA, Inc. DTEA

We’re going to add DTEA to the radar this morning. After a substantial gap-down and continued backslide on Friday, the stock gave a hint of a bottom-bounce to kick off the week yesterday along with a major influx of volume.

As you can see on the included snapshot, the stock is egregiously oversold and could be preparing for a more significant rebound, so we’ll want to be on the lookout for that.

Extended Watchlist:
RNVO, AKAO, QFOR, FDFT, REFG, PMPG

Blue Horseshoe Stocks: Updates, Bottom-Watcher & More

Updates From Last Week

Interpace Diagnostics Group, Inc. IDXG – We outlined IDXG in Thursday morning’s report, and after witnessing a low of .3619 followed by an excellent 232% pop to 1.20 on that first day, we were optimistic about our chances for seeing more new highs on Friday.

They did come, early on in the session as IDXG ripped to a new high of 1.98, bringing our two-day total observed gain on the stock to a walloping 447%

____

MJP International Ltd. MJPI

After initially alerting this stock on Wednesday at a low of .85, MJPI is another multi-dayrunner that we were tracking into the latter half of last week that ended up setting new highs on Friday.

The stock traded in a range from 1.38 and went as high as 2.02; a 46% intraday push. The new top mark, from our observed low of .85, represented an overall increase of 138% in a span of just three sessions.

Ophthotech Corp. OPHT

OPHT is setting off our bottom alarms in a big way this morning. The stock is getting absolutely massacred in the premarket in the wake of a poor clinical data release today. The stock is falling to record lows, which is always something that causes us to take note.

Whenever a knee-jerk reaction to any news sends a stock barreling down to its lowest prices ever, you can be all but certain that at some point in the near future, there’s going to be a substantial rebound. With that comes bounceplay opportunities- a chance to properly time the eventual recovery for what could be significant gains. That’s why we’re placing OPHT on intensive bottom watch in coming sessions.

Extended Watchlist:
SYRX, MEMP, CALA, NDEV, BTDG, TTCM

Blue Horseshoe Stocks: LXRX Recap & Much More

Lexicon Pharmaceuticals, Inc. LXRX

Our first order of business today is to congratulate any of our readers who were able to turn our premarket alert of LXRX into hefty intraday gains.

We were given ample opportunity to do so, as a hugely significant PR left the stock positively charged for most of the session. A momentous intraday run began from an early low of 10.83 and topped out at an HOD of 13.80. That translates to a 27% jump, which is a very impressive single-session performance for a $10 stock.

If you recall, we hit this one from multiple angles; our options trading idea of tracking Weekly $10 Calls was also good for potential profits. Those contracts traded up from a low of 1.50 all the way to 3.90, which was good for gains of up to 160%

LXRX held the majority of its daily advance, which occurred on well over 30-times the 3-month average volume. That sets the stock up with plenty of momentum, and signals us to keep an eye out in coming sessions for a continuation of such. In the event that occurs, as far as options are concerned, we’d roll our strike price up to the Weekly $12.50 Calls, which already made a heck of a move yesterday from .45-2.00.

___

Hutchinson Technology, Inc. HTCH

We also want to give a quick update on HTCH, which we entered into the conversation via Friday’s premarket report. We witnessed the beginning of its run that day with a low of 1.60, and subsequent 22% pop to 1.95.

Yesterday, the stock set a new high of 2.25, which marked a two-day increase of 41% In order for us to remain interested in this play. we’ll need to see it continue to record higher lows.

Super-Subpenny Bottom-Watchlist

Here are a couple of stocks trading in the triple-zero range that we thought were worthy of compiling into a potential bottom-play watchlist as we head into midweek. We’ll include charts for the pair illustrating the reasoning behind that:

Pervasip Corp. PVSP

B2Digital, Inc. BTDG

Extended Watchlist:
S, FIT($50-51 Weekly Calls), DAL, AAPL(Radar for Eventual Bounce)